Health / retatrutide Eli Lilly Delays Approval Bid for Obesity Drug to 2027 Retatrutide shows weight loss, heart benefits, but Lilly says it needs more QC, manufacturing data By Jenn Gidman withNewser.AI Posted Jul 23, 2026 9:14 AM CDT Copied Back